Intraregional model for end-stage liver disease score variation in liver transplantation: Disparity in our own backyard

被引:25
|
作者
Croome, Kristopher P. [1 ]
Lee, David D. [1 ]
Burns, Justin M. [1 ]
Keaveny, Andrew P. [1 ]
Taner, C. Burcin [1 ]
机构
[1] Mayo Clin Florida, Dept Transplant, 4500 San Pablo Rd, Jacksonville, FL 32224 USA
关键词
D O I
10.1002/lt.25021
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Variation in average Model for End-Stage Liver Disease (MELD) score at liver transplantation (LT) by United Network for Organ Sharing (UNOS) regions is well documented. The present study aimed to investigate MELD variation at the interregional, intraregional, and intra-donation service area (DSA) levels. Patients undergoing LT between 2015 and 2016 were obtained from the UNOS standard analysis and research file. The distribution of allocation MELD score including median, skew, and kurtosis was examined for all transplant programs. Intraregional median allocation MELD varied significantly within all 11 UNOS regions. The largest variation between programs was seen in region 5 (MELD 24.0 versus 38.5) and region 3 (MELD 20.5 versus 32.0). Regions 1, 5, and 9 had the largest proportion of programs with a highly negative skewed MELD score (50%, 57%, and 57%, respectively), whereas regions 3, 6, 10, and 11 did not have any programs with a highly negative skew. MELD score distribution was also examined in programs located in the same DSA, where no barriers exist and theoretically no significant difference in allocation should be observed. The largest DSA variation in median allocation MELD score was seen in NYRT-OP1 LiveOnNY (MELD score variation 11), AZOB-OP1 Donor Network of Arizona (MELD score variation 11), MAOB-OP1 New England Organ Bank (MELD score variation 9), and TXGC-OP1 LifeGift Organ Donation Ctr (MELD score variation 9). In conclusion, the present study demonstrates that this MELD disparity is not only present at the interregional level but can be seen within regions and even within DSAs between programs located as close as several city blocks away. Although organ availability likely accounts for a component of this disparity, the present study suggests that transplant center behavior may also play a significant role. Liver Transplantation 24 488-496 2018 AASLD.
引用
收藏
页码:488 / 496
页数:9
相关论文
共 50 条
  • [21] Pretransplant Model for End-Stage Liver Disease Score as a Predictor of Postoperative Complications After Liver Transplantation
    Siniscalchi, A.
    Cucchetti, A.
    Toccaceli, L.
    Spiritoso, R.
    Tommasoni, E.
    Spedicato, S.
    Dante, A.
    Riganello, L.
    Zanoni, A.
    Cimatti, M.
    Pierucci, E.
    Bernardi, E.
    Miklosova, Z.
    Pinna, A. D.
    Faenza, S.
    TRANSPLANTATION PROCEEDINGS, 2009, 41 (04) : 1240 - 1242
  • [22] Outcomes for patients listed for liver transplantation with a low Model for End-Stage Liver Disease (MELD) score
    Mufti, Arjmand R.
    Tanriover, Bekir
    Singal, Amit G.
    Marrero, Jorge A.
    HEPATOLOGY, 2016, 64 : 697A - 698A
  • [23] Combined Effects of Recipient Age and Model for End-Stage Liver Disease Score on Liver Transplantation Outcomes
    Sharpton, Suzanne R.
    Feng, Sandy
    Hameed, Bilal
    Yao, Francis
    Lai, Jennifer C.
    TRANSPLANTATION, 2014, 98 (05) : 557 - 562
  • [24] Model for End-Stage Liver Disease Exceptions in the Context of the French Model for End-Stage Liver Disease Score-Based Liver Allocation System
    Francoz, Claire
    Belghiti, Jacques
    Castaing, Denis
    Chazouilleres, Olivier
    Duclos-Vallee, Jean-Charles
    Duvoux, Christophe
    Lerut, Jan
    Le Treut, Yves-Patrice
    Moreau, Richard
    Mandot, Ameet
    Pageaux, Georges
    Samuel, Didier
    Thabut, Dominique
    Valla, Dominique
    Durand, Francois
    LIVER TRANSPLANTATION, 2011, 17 (10) : 1137 - 1151
  • [25] THE USE OF MELD SCORE (MODEL FOR END-STAGE LIVER DISEASE) AND DERIVATIVES IN CARDIAC TRANSPLANTATION
    Oliveira de Moraes, Ana Claudia
    Lucena da Fonseca-Neto, Olival Cirilo
    ABCD-ARQUIVOS BRASILEIROS DE CIRURGIA DIGESTIVA-BRAZILIAN ARCHIVES OF DIGESTIVE SURGERY, 2018, 31 (02):
  • [27] Relationship between model for end-stage liver disease score and left ventricular function in patients with end-stage liver disease
    Sun, Fu-Rong
    Wang, Ying
    Wang, Bing-Yuan
    Tong, Jing
    Zhang, Dai
    Chang, Bing
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2011, 10 (01) : 50 - 54
  • [28] Outcomes After Liver Transplantation in Patients Achieving a Model for End-Stage Liver Disease Score of 40 or Higher
    Alexopoulos, Sophoclis
    Matsuoka, Lea
    Cho, Yong
    Thomas, Elizabeth
    Sheikh, Mohd
    Stapfer, Maria
    Dhanireddy, Kiran
    Sher, Linda
    Selby, Rick
    Genyk, Yuri
    TRANSPLANTATION, 2013, 95 (03) : 507 - 512
  • [29] Model for end-stage liver disease (MELD) score and cost-effectiveness on living donor liver transplantation
    Takafumi Ichida
    Yutaka Narita
    Romi Murakami
    Journal of Gastroenterology, 2006, 41 : 1023 - 1024
  • [30] National Outcomes of Liver Transplantation for Model for End-Stage Liver Disease Score ≥40: The Impact of Share 35
    Nekrasov, V.
    Matsuoka, L.
    Rauf, M.
    Kaur, N.
    Cao, S.
    Groshen, S.
    Alexopoulos, S. P.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 (10) : 2912 - 2924